HyperBranch Medical Technology, Inc. announced the licensing of the Company’s OcuSeal Liquid Ocular Bandage to BD. OcuSeal is a fully synthetic ocular bandage designed as a temporary protective barrier to provide comfort for post-surgical, post-traumatic, and non-traumatic ocular conditions. BD Medical has an exclusive worldwide license from HyperBranch to market OcuSeal for use in ophthalmology. It will immediately begin to commercialize the product internationally. HyperBranch has been marketing and selling the OcuSeal Liquid Ocular Bandage since receiving CE Mark in December 2007 through independent distributors. The product is designed to help decrease surgery time, reduce the need for sutures and reduce complications typically associated with surgical incisions, including infection and patient discomfort. It is intended for direct application on corneal, conjunctival, and scleral surfaces. John Conn President and CEO of HyperBranch said "OcuSeal is a significant improvement for a variety of ophthalmic procedures, and BD is an excellent partner to offer this technology to a wider market. The transaction with an industry leader like BD further validates our platform technology and in a very sensitive field of use."